Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19

BACKGROUND: Coronavirus disease 2019 (COVID-19) patients can develop pulmonary fibrosis (PF), which is associated with impaired outcome. We assessed specific leukocytic transcriptome profiles associated with PF and the influence of early dexamethasone (DEXA) treatment on the clinical course of PF in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kooistra, Emma J., Dahm, Kilian, van Herwaarden, Antonius E., Gerretsen, Jelle, Nuesch Germano, Melanie, Mauer, Karoline, Smeets, Ruben L., van der Velde, Sjef, van den Berg, Maarten J. W., van der Hoeven, Johannes G., Aschenbrenner, Anna C., Schultze, Joachim L., Ulas, Thomas, Kox, Matthijs, Pickkers, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413531/
https://www.ncbi.nlm.nih.gov/pubmed/37559053
http://dx.doi.org/10.1186/s12931-023-02496-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413531/
https://www.ncbi.nlm.nih.gov/pubmed/37559053
http://dx.doi.org/10.1186/s12931-023-02496-1

Ejemplares similares